丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

baxalta innovations gmbh - koagulationsfaktor viii inhibitor passerende aktivitet - pulver og solvens til infusionsvæske, opløsning - 50 enheder/ml

欧盟 - 丹麦文 - EMA (European Medicines Agency)

jazz pharmaceuticals ireland limited - cannabidiol - lennox gastaut syndrome; epilepsies, myoclonic - antiepileptika, - epidyolex er indiceret til brug som supplerende behandling af anfald forbundet med lennox gastaut syndrom (lgs) eller dravet syndrom (ds), i forbindelse med clobazam, for patienter 2 år og ældre.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

novartis europharm limited  - siponimod fumarsyre - multipel sklerose, recidiverende-remitterende - selektive immunosuppressiva - mayzent er indiceret til behandling af voksne patienter med sekundær progressiv multipel sklerose (spms) med aktiv sygdom dokumenteret ved tilbagefald eller billeddiagnostiske funktioner af inflammatorisk aktivitet.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

zentiva k.s. - teriparatid - injektionsvæske, opløsning - 20 mikrogram/80 mikroliter

欧盟 - 丹麦文 - EMA (European Medicines Agency)

takeda manufacturing austria ag - humant protein c - purpura fulminans; protein c deficiency - antitrombotiske midler - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

ceva santé animale - benazepril hydrochloride, spironolactone - hjerte-kar-system - hunde - til behandling af kongestiv hjerteinsufficiens som følge af kroniske degenerative valvulær sygdom hos hunde (med vanddrivende støtte, som det er relevant).

欧盟 - 丹麦文 - EMA (European Medicines Agency)

i.d.b. radiopharmacy b.v. - lutetium (177lu) chloride - radionuklidbilleddannelse - terapeutiske radioaktive lægemidler - lumark er en radiofarmaceutisk forstadie. det er ikke beregnet til direkte brug hos patienter. dette lægemiddel må kun anvendes til radioaktivt mærkning af bærermolekyler, som er specifikt udviklet og godkendt til radioaktivt mærkning med dette radionuklid.

欧盟 - 丹麦文 - EMA (European Medicines Agency)

octapharma ab - simoctocog alfa - hemophilia a - blodkoagulationsfaktorer - behandling og profylakse af blødning hos patienter med hæmofili a (medfødt faktor viii-mangel). nuwiq kan bruges til alle aldersgrupper.